804sek
-3,1 %
Date:2025-06-26Time:15:40:19Latest report:Q1-2025List:SpotlightTicker:RESP
Market Cap:41 msekEnterprise Value:36 msekNet Sales:- msekEarnings:-7,81 msekEmployees:0ISIN:SE0023314315

Ratios

10-year key figure history for Respiratorius turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Respiratorius with index and moving average MA50 and MA200.

Stockprice:8,04
MA50:6,32
MA200:6,41
Price/MA200:25,5 %
RSI (14):60,4
Price/MA50:27,1 %

Description

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Biotechnology